Published in BMC Bioinformatics on April 10, 2006
MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res (2009) 5.70
Automatic validation of phosphopeptide identifications from tandem mass spectra. Anal Chem (2007) 1.70
METAGENassist: a comprehensive web server for comparative metagenomics. Nucleic Acids Res (2012) 1.70
Sequence features that drive human promoter function and tissue specificity. Genome Res (2010) 1.40
Classification and feature selection algorithms for multi-class CGH data. Bioinformatics (2008) 1.28
Re-sampling strategy to improve the estimation of number of null hypotheses in FDR control under strong correlation structures. BMC Bioinformatics (2007) 1.08
Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PLoS One (2012) 1.05
Signal processing for metagenomics: extracting information from the soup. Curr Genomics (2009) 1.02
Metabolism and breast cancer risk: frontiers in research and practice. J Acad Nutr Diet (2012) 0.96
Convergent Random Forest predictor: methodology for predicting drug response from genome-scale data applied to anti-TNF response. Genomics (2009) 0.95
A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping. Endocr Relat Cancer (2007) 0.95
Do serum biomarkers really measure breast cancer? BMC Cancer (2009) 0.95
Recursive cluster elimination (RCE) for classification and feature selection from gene expression data. BMC Bioinformatics (2007) 0.94
Machine learning approaches distinguish multiple stress conditions using stress-responsive genes and identify candidate genes for broad resistance in rice. Plant Physiol (2013) 0.93
Effect of finite sample size on feature selection and classification: a simulation study. Med Phys (2010) 0.92
Are there any differences between features of proteins expressed in malignant and benign breast cancers? J Res Med Sci (2010) 0.91
Revealing metabolite biomarkers for acupuncture treatment by linear programming based feature selection. BMC Syst Biol (2012) 0.91
Top scoring pairs for feature selection in machine learning and applications to cancer outcome prediction. BMC Bioinformatics (2011) 0.91
The validation and assessment of machine learning: a game of prediction from high-dimensional data. PLoS One (2009) 0.91
Classification and biomarker identification using gene network modules and support vector machines. BMC Bioinformatics (2009) 0.90
A Review of Feature Selection and Feature Extraction Methods Applied on Microarray Data. Adv Bioinformatics (2015) 0.89
Ovarian cancer classification based on dimensionality reduction for SELDI-TOF data. BMC Bioinformatics (2010) 0.87
DFP: a Bioconductor package for fuzzy profile identification and gene reduction of microarray data. BMC Bioinformatics (2009) 0.87
Segmentation of multi-isotope imaging mass spectrometry data for semi-automatic detection of regions of interest. PLoS One (2012) 0.87
Concerted down-regulation of immune-system related genes predicts metastasis in colorectal carcinoma. BMC Cancer (2014) 0.86
Identification of a small optimal subset of CpG sites as bio-markers from high-throughput DNA methylation profiles. BMC Bioinformatics (2008) 0.86
Estimation of relevant variables on high-dimensional biological patterns using iterated weighted kernel functions. PLoS One (2008) 0.85
Alignment-free supervised classification of metagenomes by recursive SVM. BMC Genomics (2013) 0.84
Biomarker discovery and redundancy reduction towards classification using a multi-factorial MALDI-TOF MS T2DM mouse model dataset. BMC Bioinformatics (2011) 0.83
Colander: a probability-based support vector machine algorithm for automatic screening for CID spectra of phosphopeptides prior to database search. J Proteome Res (2008) 0.83
A jackknife and voting classifier approach to feature selection and classification. Cancer Inform (2011) 0.82
Pairwise protein expression classifier for candidate biomarker discovery for early detection of human disease prognosis. BMC Bioinformatics (2012) 0.81
Cardiovascular genomics: a biomarker identification pipeline. IEEE Trans Inf Technol Biomed (2012) 0.81
Module-based prediction approach for robust inter-study predictions in microarray data. Bioinformatics (2010) 0.79
Two of Them Do It Better: Novel Serum Biomarkers Improve Autoimmune Hepatitis Diagnosis. PLoS One (2015) 0.79
Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays. Sci Rep (2015) 0.79
Transcriptome-wide functional characterization reveals novel relationships among differentially expressed transcripts in developing soybean embryos. BMC Genomics (2015) 0.79
A stable iterative method for refining discriminative gene clusters. BMC Genomics (2008) 0.78
Multi-omic network signatures of disease. Front Genet (2014) 0.77
A comprehensive workflow of mass spectrometry-based untargeted metabolomics in cancer metabolic biomarker discovery using human plasma and urine. Metabolites (2013) 0.77
Intoxicated Speech Detection: A Fusion Framework with Speaker-Normalized Hierarchical Functionals and GMM Supervectors. Comput Speech Lang (2014) 0.77
A data-mining approach to biomarker identification from protein profiles using discrete stationary wavelet transform. J Zhejiang Univ Sci B (2008) 0.76
A survey of computational tools for downstream analysis of proteomic and other omic datasets. Hum Genomics (2015) 0.76
Unsupervised meta-analysis on diverse gene expression datasets allows insight into gene function and regulation. Bioinform Biol Insights (2008) 0.76
Expression profiling elucidates a molecular gene signature for pulmonary hypertension in sarcoidosis. Pulm Circ (2016) 0.75
Challenges of Inversely Estimating Jacobian from Metabolomics Data. Front Bioeng Biotechnol (2015) 0.75
The Influence of the Global Gene Expression Shift on Downstream Analyses. PLoS One (2016) 0.75
A scale space approach for unsupervised feature selection in mass spectra classification for ovarian cancer detection. BMC Bioinformatics (2009) 0.75
Predictive Power Estimation Algorithm (PPEA)--a new algorithm to reduce overfitting for genomic biomarker discovery. PLoS One (2011) 0.75
Ensemble Feature Learning of Genomic Data Using Support Vector Machine. PLoS One (2016) 0.75
Robust model selection for classification of microarrays. Cancer Inform (2009) 0.75
Identification of an Efficient Gene Expression Panel for Glioblastoma Classification. PLoS One (2016) 0.75
Recursive feature selection with significant variables of support vectors. Comput Math Methods Med (2012) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A (2001) 71.82
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Use of proteomic patterns in serum to identify ovarian cancer. Lancet (2002) 16.38
Support vector machine classification and validation of cancer tissue samples using microarray expression data. Bioinformatics (2000) 13.33
Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci U S A (2002) 9.83
An overview of statistical learning theory. IEEE Trans Neural Netw (1999) 9.21
Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res (2001) 8.34
Preprocessing of oligonucleotide array data. Nat Biotechnol (2004) 4.70
A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Biostatistics (2003) 2.69
Recursive partitioning for tumor classification with gene expression microarray data. Proc Natl Acad Sci U S A (2001) 2.66
Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst (2004) 2.28
Clinical proteomics: translating benchside promise into bedside reality. Nat Rev Drug Discov (2002) 2.15
Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays. Bioinformatics (2004) 2.04
Entropy-based gene ranking without selection bias for the predictive classification of microarray data. BMC Bioinformatics (2003) 1.71
ProteinChip clinical proteomics: computational challenges and solutions. Biotechniques (2002) 1.68
Gene assessment and sample classification for gene expression data using a genetic algorithm/k-nearest neighbor method. Comb Chem High Throughput Screen (2001) 1.60
Murine histidine-rich glycoprotein: cloning, characterization and cellular origin. Immunol Cell Biol (2000) 1.03
Cancer proteomics: Serum diagnostics for tumor marker discovery. Ann N Y Acad Sci (2004) 1.00
Declining plasma fibrinogen alpha fragment identifies HER2-positive breast cancer patients and reverts to normal levels after surgery. J Proteome Res (2006) 0.96
Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics. Proteomics (2004) 0.89
Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23
Live or let die: the cell's response to p53. Nat Rev Cancer (2002) 15.06
An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nat Biotechnol (2008) 13.96
Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol (2002) 13.81
Molecular definition of breast tumor heterogeneity. Cancer Cell (2007) 12.67
Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms. Am J Hum Genet (2001) 10.48
An algorithm for finding protein-DNA binding sites with applications to chromatin-immunoprecipitation microarray experiments. Nat Biotechnol (2002) 10.23
Partition-ligation-expectation-maximization algorithm for haplotype inference with single-nucleotide polymorphisms. Am J Hum Genet (2002) 10.12
Extensive and divergent circadian gene expression in liver and heart. Nature (2002) 9.64
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell (2007) 8.94
GoSurfer: a graphical interactive tool for comparative analysis of large gene sets in Gene Ontology space. Appl Bioinformatics (2004) 7.84
Methylation of histone H3 Lys 4 in coding regions of active genes. Proc Natl Acad Sci U S A (2002) 7.67
Model-based analysis of two-color arrays (MA2C). Genome Biol (2007) 7.28
X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell (2006) 7.17
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet (2006) 7.16
Genome sequencing and analysis of the versatile cell factory Aspergillus niger CBS 513.88. Nat Biotechnol (2007) 6.21
Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol (2007) 5.68
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer. J Clin Oncol (2010) 5.50
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature (2008) 5.00
Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA (2012) 4.89
Integrating regulatory motif discovery and genome-wide expression analysis. Proc Natl Acad Sci U S A (2003) 4.74
Genomic analysis of mouse retinal development. PLoS Biol (2004) 4.66
A recurrent mutation in PALB2 in Finnish cancer families. Nature (2007) 4.64
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol (2011) 4.56
Improved response to disasters and outbreaks by tracking population movements with mobile phone network data: a post-earthquake geospatial study in Haiti. PLoS Med (2011) 4.38
Availability of consumer prices from US hospitals for a common surgical procedure. JAMA Intern Med (2013) 4.35
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA (2007) 4.33
Bayesian inference of epistatic interactions in case-control studies. Nat Genet (2007) 4.31
Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell (2007) 4.30
The Spo0A regulon of Bacillus subtilis. Mol Microbiol (2003) 4.19
Systemic endocrine instigation of indolent tumor growth requires osteopontin. Cell (2008) 3.95
The G(0)/G(1) switch gene 2 regulates adipose lipolysis through association with adipose triglyceride lipase. Cell Metab (2010) 3.61
CisModule: de novo discovery of cis-regulatory modules by hierarchical mixture modeling. Proc Natl Acad Sci U S A (2004) 3.37
FoxOs cooperatively regulate diverse pathways governing neural stem cell homeostasis. Cell Stem Cell (2009) 3.37
Residual embryonic cells as precursors of a Barrett's-like metaplasia. Cell (2011) 3.36
The program of gene transcription for a single differentiating cell type during sporulation in Bacillus subtilis. PLoS Biol (2004) 3.33
Genomic sequence is highly predictive of local nucleosome depletion. PLoS Comput Biol (2007) 3.24
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Transcriptome profiling of human and murine ESCs identifies divergent paths required to maintain the stem cell state. Stem Cells (2005) 3.16
A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol (2008) 3.13
Clinical characteristics and outcomes of Medicare patients undergoing total hip arthroplasty, 1991-2008. JAMA (2011) 3.09
Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res (2007) 3.08
The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol (2007) 3.02
Activation of innate immunity is required for efficient nuclear reprogramming. Cell (2012) 2.99
Requirement for CDK4 kinase function in breast cancer. Cancer Cell (2006) 2.92
A genome-scale analysis of the cis-regulatory circuitry underlying sonic hedgehog-mediated patterning of the mammalian limb. Genes Dev (2008) 2.66
PML, YAP, and p73 are components of a proapoptotic autoregulatory feedback loop. Mol Cell (2008) 2.66
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell (2003) 2.65
Genomic characterization of Gli-activator targets in sonic hedgehog-mediated neural patterning. Development (2007) 2.60
The sigmaE regulon and the identification of additional sporulation genes in Bacillus subtilis. J Mol Biol (2003) 2.59
Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol (2008) 2.50
HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial. J Clin Oncol (2010) 2.49
Predicting features of breast cancer with gene expression patterns. Breast Cancer Res Treat (2007) 2.49
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary. Cancer Res (2005) 2.48
Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol (2008) 2.42
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet (2003) 2.41
Impact of telemedicine intensive care unit coverage on patient outcomes: a systematic review and meta-analysis. Arch Intern Med (2011) 2.41
Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. PLoS Genet (2013) 2.39
mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev (2005) 2.37
Tight clustering: a resampling-based approach for identifying stable and tight patterns in data. Biometrics (2005) 2.37
NF-kappa B activation in human breast cancer specimens and its role in cell proliferation and apoptosis. Proc Natl Acad Sci U S A (2004) 2.33
Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis. Nat Med (2010) 2.32
Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci (2003) 2.29
Modeling within-motif dependence for transcription factor binding site predictions. Bioinformatics (2004) 2.29
Glycogen synthase kinase-3beta positively regulates the proliferation of human ovarian cancer cells. Cell Res (2006) 2.29
BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell (2002) 2.24
Insights into the multistep transformation of MGUS to myeloma using microarray expression analysis. Blood (2003) 2.23
The ecology, genetic diversity, and phylogeny of Huaiyangshan virus in China. J Virol (2011) 2.23
GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics (2012) 2.21
De novo cis-regulatory module elicitation for eukaryotic genomes. Proc Natl Acad Sci U S A (2005) 2.20
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet (2006) 2.20
A data-driven clustering method for time course gene expression data. Nucleic Acids Res (2006) 2.20
Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes (2010) 2.19
Impact of PTEN protein expression on benefit from adjuvant trastuzumab in early-stage human epidermal growth factor receptor 2-positive breast cancer in the North Central Cancer Treatment Group N9831 trial. J Clin Oncol (2013) 2.15
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Hum Mol Genet (2009) 2.13
The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP. Nat Struct Mol Biol (2007) 2.13
Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. J Clin Oncol (2011) 2.13
A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2. Cancer Cell (2009) 2.13
A role for the scaffolding adapter GAB2 in breast cancer. Nat Med (2005) 2.12
Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer. Clin Med Res (2007) 2.12
Imaging transforming growth factor-beta signaling dynamics and therapeutic response in breast cancer bone metastasis. Nat Med (2009) 2.10
Phylogenomics of nonavian reptiles and the structure of the ancestral amniote genome. Proc Natl Acad Sci U S A (2007) 2.09
Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for dose-dense every-2-week adjuvant breast cancer chemotherapy. J Clin Oncol (2005) 2.09
Syntheses and characterizations of three-dimensional channel-like polymeric lanthanide complexes constructed by 1,2,4,5-benzenetetracarboxylic acid. Inorg Chem (2002) 2.05
Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers. Cancer Res (2004) 2.05
The relationship of the intensity of posttreatment prostate-specific antigen surveillance and prostate cancer outcomes: results from a population-based cohort. Mayo Clin Proc (2012) 2.00
Trastuzumab-induced HER reprogramming in "resistant" breast carcinoma cells. Cancer Res (2009) 1.98
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol (2003) 1.96
Predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria. J Natl Cancer Inst (2011) 1.94
The association between hospital obstetrical volume and maternal postpartum complications. Am J Obstet Gynecol (2012) 1.90
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res (2010) 1.90
ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol (2004) 1.88
HapBlock: haplotype block partitioning and tag SNP selection software using a set of dynamic programming algorithms. Bioinformatics (2004) 1.86
Comparative analysis of gene sets in the Gene Ontology space under the multiple hypothesis testing framework. Proc IEEE Comput Syst Bioinform Conf (2004) 1.85
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342. J Clin Oncol (2004) 1.83